Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2005
11/08/2005US6962918 Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction
11/08/2005US6962915 Antiinflammatory agents
11/08/2005US6962908 Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
11/08/2005CA2310950C An efficacious dosage regiment of galantamine that reduces side effects
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/03/2005WO2005103263A1 Bone delivery conjugates and method of using same to target proteins to bone
11/03/2005WO2005103250A1 THERAPEUTIC MEDICINE CONTAINING MONOCLONAL ANTIBODY AGAINST FOLATE RECEPTOR BETA (FR-β)
11/03/2005WO2005103046A1 Selenophen derivatives and the use of preventing and/or treating the diseases relating to protein aging thereof
11/03/2005WO2005103015A1 Triazine compounds and their analogs, compositions, and methods
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005102381A1 Bone densifying agent characterized by use of cathepsin k inhibitor with pth
11/03/2005WO2005102362A1 Use of chondroitin sulphate e (cs-e ) for the treatment diseases or conditions related to collagen fibril formation.
11/03/2005WO2005102332A1 Therapeutic agent for arthrosis deformans
11/03/2005WO2005102331A1 Therapeutic agent for osteoporosis
11/03/2005WO2005102321A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
11/03/2005WO2005102301A2 Hydroxymethylbutyrate compositions and uses thereof
11/03/2005WO2005002555A3 Sirt1 modulators for manipulating cell/organism lifespan/stress response
11/03/2005WO2003066000A3 Formulation comprising bioactive agents and method of using same
11/03/2005US20050245741 Novel tricyclic spiropiperidines or spiropyrrolidines
11/03/2005US20050245736 Low molecular weight oversulfated polysaccharide
11/03/2005US20050245609 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
11/03/2005US20050245602 Selective estrogen receptor modulators
11/03/2005US20050245596 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245586 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12
11/03/2005US20050245575 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
11/03/2005US20050245552 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245545 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245527 Nitrogen containing heterocyclic compounds and medicines containing the same
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245514 Novel physiologically active substances
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005US20050244358 Use of mixture of sodium hyaluronate and chondroitin sulfate for use in products and therapies for cosmetic surgery
11/03/2005CA2807787A1 Hmb compositions and uses thereof
11/03/2005CA2564436A1 Use of chondroitin sulphate e (cs-e ) for the treatment of disease or conditions related to collagen fibril formation.
11/03/2005CA2562833A1 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/03/2005CA2562417A1 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005CA2560042A1 Hmb compositions and uses thereof
11/03/2005CA2559228A1 Bone delivery conjugates and method of using same to target proteins to bone
11/02/2005EP1591526A2 Frazzled nucleotide sequences, expression products, compositions and uses
11/02/2005EP1591444A1 CCR5 antagonists useful for treating aids
11/02/2005EP1591143A1 Composition comprising a combination of Calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
11/02/2005EP1591129A2 Use of neurotoxic component of botulinum toxin for treating pain associated with cervical dystonia or bepharospasm
11/02/2005EP1591122A1 Method of administering bisphosphonates
11/02/2005EP1591120A1 Receptor agonists
11/02/2005EP1590369A2 Human il-1 beta antagonists
11/02/2005EP1589989A2 Osteogenic composition
11/02/2005EP1589982A1 Packs on the base of chalk and paraffin
11/02/2005EP1516624A9 Method of producing calcium gluconolactate, compositions, processes and uses of same
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1501833B1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1501525B1 Method for producing preparations rich in tocotrienol
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1272232B1 Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1117443B1 Peptide-based carrier devices for stellate cells
11/02/2005EP1083905B1 Medical use of a selective estrogen receptor modulator in combination with a sex steroide precursor
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005EP1045833B1 2,3-substituted indole compounds as cox-2 inhibitors
11/02/2005EP0951537B1 Recombinant collagen produced by plants, methods for obtaining them and uses
11/02/2005CN1692127A TACI antibodies and uses thereof
11/02/2005CN1692123A Compounds, compositions and methods for treatment of inflammatory diseases and conditions
11/02/2005CN1692121A A full-length polynucleotide sequence coding chicken type II collagen and the use of it
11/02/2005CN1692102A Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases
11/02/2005CN1691957A 蛋白酶抑制剂 Protease inhibitors
11/02/2005CN1691947A Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1690057A Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging
11/02/2005CN1225543C Nototerygium root-eucommia wine and production method thereof
11/02/2005CN1225479C Tumour necrosis factor antibody, preparing method and medicinal composition thereof
11/02/2005CN1225282C Medicine for treating prolapse of lumber intervertebral disc
11/02/2005CN1225280C Plaster for treating prolapse of intervertebral disc
11/02/2005CN1225275C Prepared Chinese traditional medicine for hyperplastic arthritis
11/02/2005CN1225266C Medicine for treating wind rheumatism, injuries from falls and ulcer in opening of sore
11/02/2005CN1225252C Process for preparing composition comprising medicinal herb extract for preventing and treating arthritis and composition thereof
11/01/2005US6960674 A lipoxin compound for treating polymorphoneutrophil (PMN) inflammation
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960597 Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
11/01/2005US6960590 Orally active salts with tyrosine kinase activity
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors
1 ... 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 ... 820